期刊文献+

中性粒细胞/淋巴细胞比值与早期原发性肝细胞癌临床病理特征及预后的相关性 被引量:7

Correlation of neutrophil-to-lymphocyte ratio with the clinicopathological characteristics and prognosis of early primary hepatocellular carcinoma
原文传递
导出
摘要 目的:探讨中性粒细胞/淋巴细胞比值(neutrophil—to—lymphocyte ratio,NLR)与早期原发性肝细胞癌(hepatocellula rcarcinoma,HCC)临床病理特征及预后的相关性。方法:收集113例早期HCC患者与110例乙型肝炎肝硬化患者的临床资料。比较2组患者间甲胎蛋白(alpha—fetoprotein,AFP)表达量、乙型肝炎病毒(hepatitis Bvirus,HBV)-DNA、HCC病理分级和NLR等病理指标的差异。分析不同NLR(NLR〈3.65与NLR≥3.65)之间HCC患者无瘤生存率和总生成率的差异,并通过logistic回归分析影响HCC发生的因素,COX回归分析影响HCC术后复发的因素。结果:NLR在HCC组及乙型肝炎肝硬化组间差异有统计学意义(t=3.546,P〈0.05);Spearman相关分析结果显示,NLR高低与病理分化程度呈负相关(r=-0.408,P〈0.001)。log—rank检验分析结果显示,不同的NLR(NLR〈3.65与NLR≥3.65)组间HCC术后无瘤生存率差异有统计学意义嘭=40.838,P〈0.001),而总生存率差异无统计学意义(χ^2=0.046,P〉0.05);多因素logistic回归分析显示,NLR、谷丙转氨酶(alaninetransaminase,ALT)及γ-谷氨酰转肽酶(γ-glutamyl transferase,γ-GGT)对HCC发生有影响;CCX回归分析结果显示,NLR和HCC复发有关(比值比为2.271,P〈0.01)。结论:NLR高低与HCC的发生具有相关性,NLR越高HCC的分化程度越低,且术后3年内复发率越高,但与术后3年总生成率无关。 Objective: To explore the correlation of neutrophil-to-lymphocyte ratio (NLR) with the clinicopathological characteristics and prognosis of early primary hepatocellular carcinoma (HCC).Methods: The clinical data of 113 patients with early HCC and 110 patients with hepatitis B cirrhosis were collected. The expression of alpha-fetoprotein (AFP), copy number of hepatitis B virus (HBV)-DNA, pathological grade of HCC tissues, NLR and other pathological indicators between the two groups were compared. The differences in disease-free survival rate and overall survival rate were analyzed between the different levels of NLR (NLR 〈 3.65 vs NLR ≥ 3.65). The factors influencing the occurrence of HCC were analyzed by logistic regression, while the factors influencing the postoperative recurrence of HCC were analyzed by COX regression. Results: A significant difference in NLR was found between HCC and hepatitis B cirrhosis groups (t = 3.546, P 〈 0.05). Spearman correlation analysis showed that NLR was negatively correlated with the pathological differentiation degree of HCC (r = -0.408, P 〈 0.001). Logrank analysis showed that the postoperative disease-free survival rate of HCC patients was significantly different according to the different NLR (χ^2 = 40.838, P 〈 0.001), but the overall survival rate was not significantly different (χ^2 = 0.046, P 〉 0.05). Multivariate logistic regression analysis showed that the occurrence of HCC had been influenced by NLR, alanine transaminase (ALl-) and y-glutamyl transferase (y-GGT). COX regression analysis showed that NLR was correlated with the recurrence of HCC (odds ratio = 2.271, P 〈 0.01). Conclusion:NLR is correlated with the occurrence of HCC. The higher the NLR, the lower the differentiation clegree of HCC, and the higher the recurrence rate of HCC patients in 3 years after surgery. But the overall survival rate of HCC patients in 3 years after operation is not associated with NLR.
出处 《肿瘤》 CAS CSCD 北大核心 2016年第7期784-790,共7页 Tumor
基金 卫生部医药卫生科技发展研究中心资助项目(编号:W2012FZ025)~~
关键词 肝细胞 中性粒细胞/淋巴细胞比值 预后 Carcinoma, hepatocellular Neutrophil-to-lymphocyte ratio Prognosis
  • 相关文献

参考文献15

  • 1EI-Serag HB. Hepatocellular carcinoma[J]. N Engl J Med, 2011, 365(12):1118-1127.
  • 2Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer[J]. Cell, 2010, 140(6):883-899.
  • 3Sharaiha RZ, Halazun KJ, Mirza F, et al. Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer[J]. Ann Surg Oncol, 2011, 18(12):3362-3369.
  • 4Balkwill F, Mantovani A. Inflammation and cancer:back to Virchow?[J]. Lancet, 2001, 357(9255):539-545.
  • 5原发性肝癌诊疗规范(2011年版)[J].临床肿瘤学杂志,2011,16(10):929-946. 被引量:976
  • 6李友炳,杨静,张军,陈一平,刘豫瑞,江家骥.原发性肝癌肿瘤直径和假包膜与经动脉化学栓塞术疗效的关系[J].肿瘤,2014,34(8):734-738. 被引量:5
  • 7Zhou L, Rui JA, Wang SB, et al. Prognostic factors of solitary large hepatocellular carcinoma:the importance of differentiation grade[J]. Eur J Surg Oncol, 2011, 37(6):521-525.
  • 8Oh BS, Jang JW, Kwon JH, et al. Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma[J]. BMC Cancer, 2013, 13:78.
  • 9Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation[J]. Nature, 2008, 454(7203):436-444.
  • 10Keizman D, Ish-Shalom M, Huang P, et al. The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival, and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma[J]. Eur J Cancer, 2012, 48(2):202-208.

二级参考文献36

  • 1陈建国,宋新明.中国肝癌发病水平的估算及分析[J].中国肿瘤,2005,14(1):28-31. 被引量:93
  • 2Stewart BW, Kleihues P. World Cancer Report [M]. IARC, 2003 : 1-351.
  • 3Bosetti C, Levi F, Boffetta P, et al. Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004 [J]. Hepatology, 2008,48( 1 ) : 137-145.
  • 4Cho H, Hur HW, Kim SW, et al. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment [J]. Cancer Immunol Immunother, 2009,58( 1 ) : 15-23.
  • 5Halazun KJ, Aldoori A, Malik HZ, et al. Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases [J]. Eur J Surg Oncol, 2008,34( 1 ) :55-60.
  • 6Gomez D, Farid S, Malik HZ, et al. Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma [J]. World J Surg,2008,32(8):1757-1762.
  • 7Vauthey JN, Klimstra D, Franceschi D, et al. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma [ J ]. Am J Surg, 1995,169 ( 1 ) : 28- 34.
  • 8Vauthey JN, Lauwers GY, Esnaola NF, et al. Simplified staging for hepatocel|ular carcinoma [J~. J Clin Oncol, 2002, 20(6) : 1527-1536.
  • 9Lauwers GY, Terris B, Balis U J, et al. Prognostic histologic indicators of curatively resected hepatocellular carcinomas: a multi-institutional analysis of 425 patients with definition of a histologic prognostic index [J]. Am J Surg Pathol, 2002,26 ( 1 ) : 25-34.
  • 10Tsai TJ, Chau GY, Lui WY, et al. Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma [J]. Surgery, 2000, 127 (6) :603 - 608.

共引文献990

同被引文献65

引证文献7

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部